Silvio Inderbitzin, Ph.D has a successful track record in Life Sciences. After an 18-year career at Spirig Pharma he was leading the trade sale of Spirig Pharma in 2013 as delegate of the board. Since then Silvio Inderbitzin is active as a board member and an investor in various small to mid-sized Life Science companies in Switzerland. With his origin in pharmaceutical manufacturing, he built a corporate-wide GMP-quality assurance infrastructure as Head of Quality Assurance, and was responsible for product release as a Qualified Person in a medium-sized Swiss pharmaceutical company. He was later elected to the position of Technical Director and served on the Corporate Management Team, ultimately joining the Board of Directors and becoming co-owner of the privately-held 450 employee company. Prior to the successful sale of the company, he served as CEO and was responsible for its foreign subsidiaries. Dr. Inderbitzin studied Pharmacy at the University of Berne, holds a Ph.D. in Pharmacology from the University of Zurich/ETH, and obtained an Executive MBA from the University of St. Gallen.